Log in

NASDAQ:KALAKala Pharmaceuticals Earnings Date, Estimates & History

-0.25 (-2.73 %)
(As of 08/7/2020 04:00 PM ET)
Today's Range
Now: $8.92
50-Day Range
MA: $10.49
52-Week Range
Now: $8.92
Volume604,991 shs
Average Volume825,788 shs
Market Capitalization$486.76 million
P/E RatioN/A
Dividend YieldN/A


Kala Pharmaceuticals (NASDAQ:KALA) Earnings Information

Kala Pharmaceuticals last announced its earnings results on August 6th, 2020. The reported ($0.42) earnings per share for the quarter, hitting analysts' consensus estimates of ($0.42). Kala Pharmaceuticals has generated ($2.76) earnings per share over the last year. Kala Pharmaceuticals has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 5th, 2020 based off prior year's report dates.

Kala Pharmaceuticals Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Kala Pharmaceuticals (NASDAQ:KALA) Earnings Estimates

2020 EPS Consensus Estimate: ($1.52)
2021 EPS Consensus Estimate: ($1.27)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20202($0.63)($0.30)($0.47)
Q2 20201($0.28)($0.28)($0.28)
Q3 20202($0.60)($0.23)($0.42)
Q4 20202($0.44)($0.28)($0.36)
Q1 20211($0.36)($0.36)($0.36)
Q2 20211($0.35)($0.35)($0.35)
Q3 20211($0.31)($0.31)($0.31)
Q4 20211($0.25)($0.25)($0.25)

Kala Pharmaceuticals (NASDAQ KALA) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
5/7/20203/31/2020($0.51)($0.54)($0.54)$2.49 million$1.07 millionListen
2/12/2020Q4($0.60)($0.63)($0.63)$2.92 million$1.18 millionTranscript
11/7/2019Q3($0.67)($0.68)($0.68)$3.56 million$1.45 millionListen
8/6/2019Q2 2019($0.74)($0.70)($0.70)$2.62 million$2.06 millionN/A
5/9/20193/31/2019($0.75)($0.75)($0.73)$0.96 million$1.39 millionN/A
3/11/2019Q4 2018($0.52)($0.75)($0.74)N/A
8/9/2018Q2 2018($0.4950)($0.60)($0.60)N/A
5/10/2018Q1 2018($0.4620)($0.46)($0.46)N/A
3/26/2018Q4 2017($0.37)($0.46)($0.46)Transcript
11/7/2017Q3 2017($0.4250)($0.56)($0.56)N/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 8/9/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.